Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA86296
Max Phase: Preclinical
Molecular Formula: C11H10ClNO2
Molecular Weight: 223.66
Molecule Type: Small molecule
Associated Items:
ID: ALA86296
Max Phase: Preclinical
Molecular Formula: C11H10ClNO2
Molecular Weight: 223.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccccc1-c1cc(CCl)on1
Standard InChI: InChI=1S/C11H10ClNO2/c1-14-11-5-3-2-4-9(11)10-6-8(7-12)15-13-10/h2-6H,7H2,1H3
Standard InChI Key: SFVUMAUIGYTCFT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 223.66 | Molecular Weight (Monoisotopic): 223.0400 | AlogP: 3.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 35.26 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.72 | CX LogD: 2.72 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.75 | Np Likeness Score: -1.17 |
1. Sammelson RE, Ma T, Galietta LJ, Verkman AS, Kurth MJ.. (2003) 3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators., 13 (15): [PMID:12852954] [10.1016/s0960-894x(03)00482-7] |
Source(1):